
Firefly Neuroscience
Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.
About
Firefly Neuroscience is dedicated to improving outcomes for individuals with mental illnesses by offering clinicians and patients an objective and age-matched assessment of brain function (cognition). Their FDA-cleared Brain Network Analytics (BNA™) technology helps healthcare professionals make more informed decisions.
Key facts
At-a-glance profile data
- Website
- fireflyneuro.com
- Headquarters
- San Francisco, United States
- Founded
- 2006
- Employees
- 25
- Total funding
- $45M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 31 Oct 2015 | Series C | $28M | - |
| 30 Nov 2011 | Undisclosed round | $14M | - |
| 31 May 2006 | Undisclosed round | $4M | - |
Tech stack
Detected on fireflyneuro.com, last scanned 2 Aug 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4, Google Tag Manager
- SEO
- Yoast SEO
- Support
- HubSpot
- CMS / Builders
- WordPress
- Hosting
- AWS
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has Firefly Neuroscience raised?
Firefly Neuroscience has raised a total of $45M in funding. The most recent round on record is Series C.
How many employees does Firefly Neuroscience have?
Firefly Neuroscience has approximately 25 people on record.